The European Medicines Verification Organisation (EMVO) is responsible for implementing and managing the European Medicines Verification System (EMVS), a pan-European system designed to prevent counterfeit medicines from entering the legitimate supply chain.
EMVO ensures the authenticity of medicinal products by enabling verification of unique identifiers on pharmaceutical packaging through a comprehensive verification network across all EU member states.
Establishing and maintaining the European Medicines Verification System
Coordinating verification systems across all EU member states
Working with National Medicines Verification Organisations
Ensuring adherence to Falsified Medicines Directive requirements
Central system that coordinates verification requests and manages data exchange between national systems and stakeholders.
Country-specific systems operated by National Medicines Verification Organisations (NMVOs) that handle local verification processes.
Integration with pharmaceutical manufacturers, wholesalers, pharmacies, and other supply chain participants for seamless verification.
Falsified Medicines Directive became effective on February 9, 2019, mandating safety features on prescription medicines.
EMVO continues to enhance the EMVS with new features, improved security, and expanded functionality to meet evolving regulatory requirements.
Information may be outdated. Always consult official documentation from EMVO, EMA, GS1, and national regulatory bodies for current requirements.